Market revenue in 2023 | USD 348.5 million |
Market revenue in 2030 | USD 695.1 million |
Growth rate | 10.4% (CAGR from 2023 to 2030) |
Largest segment | 32-channel eeg |
Fastest growing segment | Multichannel EEG |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | 8-channel EEG, 21-channel EEG, 25-channel EEG, 32-channel EEG, 40-channel EEG, Multichannel EEG |
Key market players worldwide | Natus Medical, Medtronic PLC, Nihon Kohden Corp, Brain Products, Philips, AMS Micromedical, Emotiv, ANT Neuro, Lifelines Neuro, Cadwell Laboratories, EB Neuro, The Magstim Company, Compumedics |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to electroencephalography devices market will help companies and investors design strategic landscapes.
32-channel eeg was the largest segment with a revenue share of 27.46% in 2023. Horizon Databook has segmented the U.S. electroencephalography devices market based on 8-channel eeg, 21-channel eeg, 25-channel eeg, 32-channel eeg, 40-channel eeg, multichannel eeg covering the revenue growth of each sub-segment from 2018 to 2030.
The favorable reimbursement scenario provides access to healthcare services related to brain treatment to a large portion of the population. Subsequently, it creates a demand for cost-effective and efficient electroencephalography devices.
This also increases the need for cost-effective electroencephalography devices and the integration of digital health into the care delivery system. Hence, many companies are seeking U.S. FDA approval to launch their products in the U.S. market.
For instance, in January 2022, Neurosteer Inc. announced that it received approval from the U.S. FDA for its single-channel Electroencephalogram (EEG) brain monitoring platform. This system helps in the early detection of presymptomatic cognitive diseases, such as Alzheimer’s, dementia, and Parkinson’s.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. electroencephalography devices market , including forecasts for subscribers. This country databook contains high-level insights into U.S. electroencephalography devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account